Cargando…

A Comparative Evaluation of a Novel Vaccine in APP/PS1 Mouse Models of Alzheimer's Disease

Immunization against amyloid-beta-peptide (Aβ) has been widely investigated as a potential immunotherapeutic approach for Alzheimer's disease (AD). With the aim of developing an active immunogenic vaccine without need of coadjuvant modification for human trials and therefore avoiding such side...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carrera, Iván, Etcheverría, Ignacio, Fernández-Novoa, Lucía, Lombardi, Valter Ruggero Maria, Lakshmana, Madepalli Krishnappa, Cacabelos, Ramón, Vigo, Carmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339718/ https://www.ncbi.nlm.nih.gov/pubmed/25759822 http://dx.doi.org/10.1155/2015/807146

Ejemplares similares

Vaccine Development to Treat Alzheimer's Disease Neuropathology in APP/PS1 Transgenic Mice
por: Carrera, Iván, et al.
Publicado: (2012)

Immunocytochemical Characterization of Alzheimer Disease Hallmarks in APP/PS1 Transgenic Mice Treated with a New Anti-Amyloid-β Vaccine
por: Carrera, Iván, et al.
Publicado: (2013)

Immunocytochemical Characterization of Alzheimer’s Disease Hallmarks in APP/PS1 Transgenic Mice Treated with a New Anti-Amyloid-β Vaccine
por: Carrera, Ivan, et al.
Publicado: (2014)

Prevention of Chronic Experimental Colitis Induced by Dextran Sulphate Sodium (DSS) in Mice Treated with FR91
por: Lombardi, Valter R. M., et al.
Publicado: (2012)

Epigenetic Studies in the Male APP/BIN1/COPS5 Triple-Transgenic Mouse Model of Alzheimer’s Disease
por: Martínez-Iglesias, Olaia, et al.
Publicado: (2022)

In vitro and in vivo cytotoxic effect of AntiGan against tumor cells
por: Lombardi, Valter R.M., et al.
Publicado: (2018)

In Vitro Screening for Cytotoxic Activity of Herbal Extracts
por: Lombardi, Valter R. M., et al.
Publicado: (2017)

DNA Methylation in Neurodegenerative and Cerebrovascular Disorders
por: Martínez-Iglesias, Olaia, et al.
Publicado: (2020)

Genomics of Dementia: APOE- and CYP2D6-Related Pharmacogenetics
por: Cacabelos, Ramón, et al.
Publicado: (2012)

Influence of Pathogenic and Metabolic Genes on the Pharmacogenetics of Mood Disorders in Alzheimer’s Disease
por: Cacabelos, Ramón, et al.
Publicado: (2021)

Neuroprotective Effect of Nosustrophine in a 3xTg Mouse Model of Alzheimer’s Disease
por: Carrera, Iván, et al.
Publicado: (2023)

Resting-State Network Disruption and APOE Genotype in Alzheimer's Disease: A lagged Functional Connectivity Study
por: Canuet, Leonides, et al.
Publicado: (2012)

Nutrition, Health, and Disease: Role of Selected Marine and Vegetal Nutraceuticals
por: Corzo, Lola, et al.
Publicado: (2020)

TFEB Overexpression in the P301S Model of Tauopathy Mitigates Increased PHF1 Levels and Lipofuscin Puncta and Rescues Memory Deficits12
por: Wang, Hongjie, et al.
Publicado: (2016)

C-terminal 37 residues of LRP promote the amyloidogenic processing of APP independent of FE65
por: Lakshmana, Madepalli K, et al.
Publicado: (2008)

Transcription Factor EB Is Selectively Reduced in the Nuclear Fractions of Alzheimer's and Amyotrophic Lateral Sclerosis Brains
por: Wang, Hongjie, et al.
Publicado: (2016)

Novel Alzheimer risk factor IQ motif containing protein K is abundantly expressed in the brain and is markedly increased in patients with Alzheimer’s disease
por: Wang, Hongjie, et al.
Publicado: (2022)

SARS-CoV-2-induced autophagy dysregulation may cause neuronal dysfunction in COVID-19
por: Lakshmana, Madepalli K.
Publicado: (2021)

Future Trends in the Pharmacogenomics of Brain Disorders and Dementia: Influence of APOE and CYP2D6 Variants
por: Cacabelos, Ramón, et al.
Publicado: (2010)

Striking reduction of amyloid plaque burden in an Alzheimer's mouse model after chronic administration of carmustine
por: Hayes, Crystal D, et al.
Publicado: (2013)

RanBP9 Overexpression Accelerates Loss of Pre and Postsynaptic Proteins in the APΔE9 Transgenic Mouse Brain
por: Wang, Hongjie, et al.
Publicado: (2014)

Correction: RanBP9 Overexpression Accelerates Loss of Pre and Postsynaptic Proteins in the APΔE9 Transgenic Mouse Brain
por: Wang, Hongjie, et al.
Publicado: (2019)

Nosustrophine: An Epinutraceutical Bioproduct with Effects on DNA Methylation, Histone Acetylation and Sirtuin Expression in Alzheimer’s Disease
por: Martínez-Iglesias, Olaia, et al.
Publicado: (2022)

Current Drugs and Potential Future Neuroprotective Compounds for Parkinson’s Disease
por: Carrera, Iván, et al.
Publicado: (2019)

Effects of FR-91 on Immune Cells from Healthy Individuals and from Patients with Non-Hodgkin Lymphoma
por: Lombardi, V. R. M., et al.
Publicado: (2009)

Personalized Medicine of Alzheimer’s Disease
por: Cacabelos, Ramón, et al.
Publicado: (2014)

Histamine and Immune Biomarkers in CNS Disorders
por: Cacabelos, Ramón, et al.
Publicado: (2016)

Cardiovascular and lipid-lowering effects of a marine lipoprotein extract in a high-fat diet-induced obesity mouse model
por: Carrera, Iván, et al.
Publicado: (2023)

Donepezil in Alzheimer’s disease: From conventional trials to pharmacogenetics
por: Cacabelos, Ramón
Publicado: (2007)

Comprehensive behavioral characterization of an APP/PS-1 double knock-in mouse model of Alzheimer's disease
por: Webster, Scott J, et al.
Publicado: (2013)

Milrinone Ameliorates the Neuroinflammation and Memory Function of Alzheimer’s Disease in an APP/PS1 Mouse Model
por: Chen, Qingyou, et al.
Publicado: (2021)

Neuroprotective effects of resistance physical exercise on the APP/PS1 mouse model of Alzheimer’s disease
por: Campos, Henrique Correia, et al.
Publicado: (2023)

An integrated proteomics approach shows synaptic plasticity changes in an APP/PS1 Alzheimer's mouse model
por: Kempf, Stefan J., et al.
Publicado: (2016)

Humulus japonicus inhibits the progression of Alzheimer's disease in a APP/PS1 transgenic mouse model
por: Park, Tae-Shin, et al.
Publicado: (2017)

Active compounds of herbs ameliorate impaired cognition in APP/PS1 mouse model of Alzheimer’s disease
por: Yu, WenJun, et al.
Publicado: (2019)

The role of ADAM17 in cerebrovascular and cognitive function in the APP/PS1 mouse model of Alzheimer’s disease
por: Tian, Yanna, et al.
Publicado: (2023)

Neuroprotective Effects of Leptin on the APP/PS1 Alzheimer’s Disease Mouse Model: Role of Microglial and Neuroinflammation
por: Ma, Jing, et al.
Publicado: (2023)

Pharmacogenetics of Vascular Risk Factors in Alzheimer’s Disease
por: Cacabelos, Ramón, et al.
Publicado: (2018)

Potential Role of Phosphoglycerol Dihydroceramide Produced by Periodontal Pathogen Porphyromonas gingivalis in the Pathogenesis of Alzheimer’s Disease
por: Yamada, Chiaki, et al.
Publicado: (2020)

Epigenetics of Aging and Alzheimer’s Disease: Implications for Pharmacogenomics and Drug Response
por: Cacabelos, Ramón, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tjod6ii3irqapeopba6ffl4ho9